je.st
news
This Biotech ETF Has Thus Far Delivered On Its Potential
2015-09-28 21:37:26| Biotech - Topix.net
The ALPS Medical Breakthroughs ETF - a fund focused on companies in late stage clinical trials - has jumped over 20% YTD, far outperforming small cap & biotech counterparts. The fund's managers have demonstrated a solid albeit short track record over the ETF's nine month history outperforming small cap, biotech and pharma indices.
Tags: its
potential
delivered
biotech
Category:Biotechnology and Pharmaceuticals